Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Completed

Conditions studied: Liver Cancer

In brief

Primary Objective: 1\. To compare the efficacy of 1.5T vs. 3T T1 and T2-weighted MR images sequences for the detection and evaluation of liver lesions.

Key facts

Study ID

NCT00527891

Run by

M.D. Anderson Cancer Center

People needed

16

Starts

2004-06-01

Last updated by the study team

2012-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a liver lesion larger than 1cm detected by a prior imaging modality.
• Patients have been scheduled and are eligible for an MRI of the abdomen or MRI of the liver or MRI of the kidney examination.

You may not qualify if…

• Patients who are unable to cooperate with breath hold.

Where it is running

• U.T.M.D. Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.